Log In
Print
BCIQ
Print
Print this Print this
 

A4250

  Manage Alerts
Collapse Summary General Information
Company Albireo AB
DescriptionInhibitor of solute carrier family 10 sodium-dependent bile acid transporter member 2 (IBAT; SLC10A2; ASBT)
Molecular Target Solute carrier family 10 sodium-dependent bile acid transporter member 2 (SLC10A2) (ASBT) (IBAT)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationCirrhosis
Indication DetailsTreat primary biliary cirrhosis (PBC)
Regulatory Designation

U.S. - Orphan Drug (Treat primary biliary cirrhosis (PBC));
EU - Orphan Drug (Treat primary biliary cirrhosis (PBC))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today